Neoadjuvant Clinical Trial With Sorafenib for Patients With Stage II or Higher Renal Cell Carcinoma

Complete Histologic Remission after Sunitinib Neoadjuvant Therapy in T3b Renal Cell Carcinoma

(2009) Grégoire Robert et al.   EUROPEAN UROLOGY

Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell Carcinoma

(2009) Eric Jonasch et al.   JOURNAL OF CLINICAL ONCOLOGY

Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery

(2009) Axel Bex et al.   WORLD JOURNAL OF UROLOGY

Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm

(2008) Brian Shuch et al.   BJU INTERNATIONAL

Surgical Morbidity Associated With Administration of Targeted Molecular Therapies Before Cytoreductive Nephrectomy or Resection of Locally Recurrent Renal Cell Carcinoma

(2008) Vitaly Margulis et al.   JOURNAL OF UROLOGY

Response of the Primary Tumor to Neoadjuvant Sunitinib in Patients With Advanced Renal Cell Carcinoma

(2008) Anil A. Thomas et al.   JOURNAL OF UROLOGY

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

(2008) Robert J Motzer et al.   LANCET

Preoperative Tyrosine Kinase Inhibition as an Adjunct to Debulking Nephrectomy

(2008) Chirag Amin et al.   UROLOGY

Neoadjuvant Sutent Induction Therapy May Effectively Down-Stage Renal Cell Carcinoma Atrial Thrombi

(2007) Pierre I. Karakiewicz et al.   EUROPEAN UROLOGY